Crinetics Pharmaceuticals, Inc. (CRNX) Sentiment
30-day sentiment Neutral · ▬ steady · as of 2026-11-08
CRNX sentiment is neutral over the last 30 days and holding steady; there is no reading for today yet. Most of the conversation is on News. SentiSense tracks CRNX sentiment daily across news and social media.
- Sentiment (30-day)
- Neutral
- Today's read
- No reading yet today
- Trend (30-day)
- Steady
Where the conversation is happening
- News
- Bullish
Related tickers
What's driving it
- Vertex Q2 Revenue Beats, Adjusted EPS Narrowly Misses, FY26 Revenue Guidance Raised
- Vertex Pharmaceuticals Acquires Crinetics Pharmaceuticals for $10B
- Pharma Companies Report Promising Phase 2 Trial Results
SentiSense tracks Crinetics Pharmaceuticals, Inc. (CRNX) sentiment daily. The live SentiSense Score, its history, and the per-source breakdown are on this page in the SentiSense app.
See how CRNX's sector compares in the market sentiment heatmap